Veterinärmedizinische Universität Wien Forschungsinformationssystem VetDoc

Grafischer Link zur Startseite der Vetmeduni Vienna

Wolfesberger Birgitt,

** = Publikationen gelistet in SCI/SSCI/Pubmed

2020

Zeitschriftenaufsatz

** Škor, O; Bicanová, L; Wolfesberger, B; Fuchs-Baumgartinger, A; Ruetgen, B; Štěrbová, M; Schwendenwein, I; Kleiter, M (2020): Are B-symptoms more reliable prognostic indicators than substage in canine nodal diffuse large B-cell lymphoma. Vet Comp Oncol. 2020;
[Article in Press]

2019

** Kieslinger, M; Swoboda, A; Kramer, N; Pratscher, B; Wolfesberger, B; Burgener, IA (2019): Companion Animals as Models for Inhibition of STAT3 and STAT5. Cancers (Basel). 2019; 11(12):2035
Open Access Logo

Kongressbeitrag in einer Zeitschrift

Škor, O; Miller, I; Wolfesberger, B; Řeháková, K; Škorová, K; Guija, A; Rütgen, B; Kleiter, M; Schwendenwein, I (2019): Presence of monoclonal gammopathy in canine nodal diffuse large B-cell Lymphoma. ESVCP-ECVCP Annual Congress, Arnhem, Netherlands, SEP 25-28, 2019. Veterinary Clinical Pathology 15-15.

Škor, O; Wolfesberger, B; -Baumgartinger, A;Řeháková, K; Škorová, K; Rütgen, B; Kleiter, M; Schwendenwein, I (2019): Pretreatment leukocyte ratios as predictors of outcome in canine diffuse large B-cell lymphoma. ESVCP-ECVCP Annual Congress, Arnhem, Netherlands, SEP 25-28, 2019. Veterinary Clinical Pathology 7-7.

Publizierter (zitierfähiger) Beitrag für wissenschaftliche Veranstaltung in Proceedings (A2)

Hammer, SE; Luckschander-Zeller, N; Skor, O; Wolfesberger, B; Baumgartner, D; Groiss, S; Guija de Arespacochaga, A; Schwendenwein, I; Rütgen, BC (2019): Potential and Limitations in Clonality Testing – Experiences with Clinical cases. 27--4th Meeting of the European Canine Lymphoma Network Workshop on canine lymphoma (ECLN 2017); June 22, 2019; Lugano, Switzerland.

Kleiter, M; Reinhalter, L; Tichy, A; Pagitz, M; Kreilmeier-Berger, T; Wolfesberger, B (2019): Re-irradiation is a valuable treatment option for dogs and cats with cancer after failing first line therapy. -29th Annual ECVIM-CA Congress; SEP 18-21, 2019; Milano, Italy.

Škor, O; Bicanova, L; Wolfesberger, B; Fuchs-Baumgartinger, A; Aresu, L; Pfeifr, J; Faldyna, M; Rütgen, B; Kleiter, M; Marconato, L (2019): Outcome of CHOP, LOPP and VELCAP-TSC as first-line treatment for canine peripheral T-cell lymphoma. 118-118.-VCS Annual Conference; OCT 17-19, 2019; Houston, United States (USA).

Škor, O; Hittmair, K; Fuchs-Baumgartinger, A; Bicanova, L; Guija de Arespacochaga, A; Pfeifr, J; Pagitz, M; Wolfesberger, B; Kleiter, M (2019): Time to change from WHO staging to Ann-Arbor system in canine nodal diffuse large B-celll lymphoma. -29th Annual ECVIM-CA Congress; SEP 18-21, 2019; Milano, Italy.

Škor, O; Miller, I; Wolfesberger, B; Řeháková, K; Škorová, K; Guija, A; Rütgen, B; Kleiter, M; Schwendenwein, I (2019): Presence of monoclonal gammopathy in canine nodal diffuse large B-cell Lymphoma. -ESVCP-ECVCP Annual Congress; SEP 25-28, 2019; Arnhem, Netherlands.

Škor, O; Pagitz, M; Fuchs-Baumgartinger, A; Pfeifr, J; Ingelbert, M; Ruetgen, B; Štěrbová, M; Wolfesberger, B; Kleiter, M (2019): Are B-symptoms more valuable than substage B to predict prognosis in canine nodal diffuse large B-cell lymphoma? 26-26.-4th ECLN Meeting; JUN 22, 2019; Lugano, Switzerland.

Škor, O; Wolfesberger, B; Fuchs-Baumgartinger, A; Řeháková, K; Škorová, K; Rütgen, B; Kleiter, M; Schwendenwein, I (2019): Pretreatment leukocyte ratios as predictors of outcome in canine diffuse large B-cell lymphoma. -ESVCP-ECVCP Annual Congress; SEP 25-28, 2019; Arnhem, Netherlands.

Škor, O; Wolfesberger, B; Fuchs-Baumgartinger, A; Reháková, K; Bicanová, L; Faldyna, M; Schwendenwein, I; Kleiter, M (2019): Humoral Hypercalcemia of Malignancy in Canine Lymphoma WHO Types and Its Impact on Survival. -29th Annual ECVIM-CA Congress; SEP 18-21, 2019; Milano, Italy.

Škor, O; Wolfesberger, B; Kehl, A; Molinkova, D; Müller, E; Walter, I; Crha, M; Leschnik, M; Kleiter, M (2019): Occurrence of vector-borne pathogens in canine nodal lymphomas. 25-25.-4th ECLN Meeting; JUN 22, 2019; Lugano, Switzerland.

2018

Zeitschriftenaufsatz

** Wolfesberger, B; Fuchs-Baumgartinger, A; Greß, V; Hammer, SE; Gradner, G; Knödl, K; Tichy, A; Rütgen, BC; Beham-Schmid, C (2018): World Health Organisation Classification of Lymphoid Tumours in Veterinary and Human Medicine: a Comparative Evaluation of Gastrointestinal Lymphomas in 61 Cats. J Comp Pathol. 2018; 159:1-10

Publizierter (zitierfähiger) Beitrag für wissenschaftliche Veranstaltung in Proceedings (A2)

Kleiter, M; Krupp, S; Tichy, A; Pagitz, M; Skor, O; Wolfesberger, B (2018): Palliative radiotherapy in 78 dogs and cats with various spontaneous tumors. -ACVR annual congress; OCT 14-19, 2018; Forth Worth, Texas, United States (USA).

Rütgen, B; Hammer, S; Wolfesberger, B; Groiss, S; Baumgartner, D; Saalmüller, A; Schwendenwein, I (2018): Phenotype Reference Data Of Normal Feline Lymph Nodes. -ACVP and ASVCP Concurrent Annual Meeting; Nov 3-7, 2018; Washington, DC, United States (USA).

Wolfesberger, B (2018): Felines und kanines GI Lymphom: Aktueller Stand zu Diagnostik und Therapie. 241-243.-64. Jahreskongress der DVG; OCT 4-7, 2018; Berlin, Germany.

Wolfesberger, B (2018): Gastrointestinal lymphoma: comparative aspects. 69-76.-Canine Lymphoma Meeting; MAY 4, 2018; Vienna, Austria.

2017

Zeitschriftenaufsatz

** Hlavaty, J; Wolfesberger, B; Hauck, M; Obermayer-Pietsch, B; Fuchs-Baumgartinger, A; Miller, I; Walter, I (2017): Ezrin and moesin expression in canine and feline osteosarcoma. Histol Histopathol. 2017; 32(8):805-816

** Skor, O; de Arespacochaga, AG; Rütgen, BC; Hammers, SE; Wolfesberger, B; Springler, G; Loerincz, B; Kleiter, M (2017): Cutaneous non-epitheliotropic T-cell lymphoma - the great impostor. Wien Tierarztl Monat (104), 3-4 63-73.

** Wolfesberger, B; Skor, O; Hammer, SE; Flickinger, I; Kleiter, M; Rütgen, BC; Schwendenwein, I; Tichy, A; Hittmair, KM; Degasperi, B; Fuchs-Baumgartinger, A (2017): Does categorisation of lymphoma subtypes according to the World Health Organization classification predict clinical outcome in cats? J Feline Med Surg. 2017; 19(8):897-906

Publizierter (zitierfähiger) Beitrag für wissenschaftliche Veranstaltung in Proceedings (A2)

Künzel, F; Szikszai, F; Eördogh, R; Stanclova, G; Schwendenwein, I; Wolfesberger, B; Bilek, A; Fuchs-Baumgartinger, A (2017): Bilateral uveal metastasis due to a mammary adenocarcinoma in a rabbit. 728-728.-3rd International Conference on Avian herpetological and Exotic mammal medicine; MAR 25-29, 2017; Venice, Italy.

Rütgen, BC; Gerner, W; Skor, O; Flickinger, I; Wolfesberger, B; Schwendenwein I (2017): Results of flow-cytometric immunophenotyping in canine multicentric lymphoma - 73 cases. -ESVCP Annual Meeting; SEP 7-9, 2017; London, United Kingdom.

Populärwissenschaftlicher Artikel

Wolfesberger, B (2017): Das alimentäre Lymphom der Katze. Mein Haustier : Gesundheitsmagazin für Tiere 26-27.

2016

Zeitschriftenaufsatz

** Gress, V; Wolfesberger, B; Fuchs-Baumgartinger, A; Nedorost, N; Saalmüller, A; Schwendenwein, I; Rütgen, BC; Hammer, SE (2016): Characterization of the T-cell receptor gamma chain gene rearrangements as an adjunct tool in the diagnosis of T-cell lymphomas in the gastrointestinal tract of cats. Res Vet Sci. 2016; 107:261-266

** Rütgen, BC; Flickinger, I; Wolfesberger, B; Litschauer, B; Fuchs-Baumgartinger, A; Hammer, SE; Saalmüller, A; Schwendenwein, I (2016): Cutaneous T-cell lymphoma - Sézary syndrome in a Boxer. Vet Clin Pathol. 2016; 45(1):172-178

** Wolfesberger, B; Fuchs-Baumgartinger, A; Hlavaty, J; Meyer, FR; Hofer, M; Steinborn, R; Gebhard, C; Walter, I (2016): Stem cell growth factor receptor in canine vs. feline osteosarcomas. Oncol Lett. 2016; 12(4):2485-2492
Open Access Logo

Publizierter (zitierfähiger) Beitrag für wissenschaftliche Veranstaltung in Proceedings (A2)

Gress, V; Wolfesberger, B; Fuchs-Baumgartinger, A; Nedorost, N; Saalmüller, A; Schwendenwein, I; Rütgen, BC; Hammer, SE (2016): Characterization of the T-cell receptor gamma chain gene rearrangements as an adjunct tool in the diagnosis of alimentary T-cell lymphomas in cats. 264--DGfI 2016; SEP 27-30, 2016; Hamburg, GERMANY.

Wolfesberger, B (2016): Alimentäres Lymphom der Katze. -32. VÖK-Jahrestagung; SEP 15-19, 2017; Salzburg, Austria.

Originalbeitrag in Sammelwerk

Wolfesberger, B (2016): Wie führe ich eine Euthanasie bei Hunden und Katzen durch? IN: Bundesverband der Veterinärmedizinstudierenden Deutschland [Hrsg.]: FAQ - Berufseinstieg Kleintierpraxis. Stuttgart, Enke, pp. 48-49. ISBN: 978-3-13-219781-7.

2015

Zeitschriftenaufsatz

** Meyer, FR; Steinborn, R; Grausgruber, H; Wolfesberger, B; Walter, I (2015): Expression of platelet-derived growth factor BB, erythropoietin and erythropoietin receptor in canine and feline osteosarcoma. Vet J. 2015; 206(1):67-74
Open Access Logo

Publizierter (zitierfähiger) Beitrag für wissenschaftliche Veranstaltung in Proceedings (A2)

Hammer, SE; Gress, V; Wolfesberger, B; Fuchs-Baumgartinger, A; Nedorost, N; Saalmüller, A; Schwendenwein, I; Rütgen, BC (2015): PCR for antigen receptor gene rearrangement (PARR) as an adjunct tool in the characterisation of intestinal lymphomas in cats. 173--EVIW 2015; SEP 2-4, 2015; Vienna, AUSTRIA.

Rütgen, BC; Gerner, W; Flickinger, I; Wolfesberger, B; Schwendenwein, I (2015): Immunophenotyping of Canine Leukemia by Flow Cytometry– 42 Cases. -ESVONC 2015; Mai 28-30, 2015; Krakow, POLAND.

2014

Zeitschriftenaufsatz

** Walter, I; Wolfesberger, B; Miller, I; Mair, G; Burger, S; Gallè, B; Steinborn, R (2014): Human osteosarcoma cells respond to sorafenib chemotherapy by downregulation of the tumor progression factors S100A4, CXCR4 and the oncogene FOS. Oncol Rep. 2014; 31(3):1147-1156

Kongressbeitrag in einer Zeitschrift

Flickinger, I; Wolfesberger, B; Pagitz, M; Willmann, M; Kleiter, M (2014): Adjuvant Immunotherapy for canine malignant melanoma patients with ONCEPT TM: A single center experience. 23. ECVIM Congress, Liverpool, UNITED KINGDOM, United Kingdom, SEP 12-14, 2013. Journal of Veterinary Internal Medicine (12), 1 e7.

Publizierter (zitierfähiger) Beitrag für wissenschaftliche Veranstaltung in Proceedings (A2)

Kleiter, M; Moser, M; Flickinger, I; Pagitz, M; Willmann, M; Tichy, A; Wolfesberger, B (2014): Radiotherapy in the treatment of 32 canine subcutaneous soft tissue sarcomas. -ECVIM-Ca congress; Sept 4-6, 2014; Mainz, Germany.

Kleiter, M; Pernkopf, C; Tichy, A; Flickinger, I; Pagitz, M; Willmann, M; Kosik, S; Wolfesberger, B (2014): First patient cohort of canine nasosinal tumors treated with radiotherapy at the University of Veterinary Medicine Vienna. 106--ESVONC congress; Mai 22-24, 2014; Vienna, Austria.

2013

Zeitschriftenaufsatz

** Flickinger, I; Pakozdy, A; Leschnik, M; Kneissl, S; Tichy, A; Wolfesberger, B; Kleiter, M (2013): Radiation therapy and outcome in dogs with intracranial neoplasms: 35 cases. Wien Tierarztl Monat (100), 7-8 163-170.

Kongressbeitrag in einer Zeitschrift

Flickinger, I; Pakozdy, A; Leschnik, M; Kneissl, S; Tichy, A; Wolfesberger, B; Kleiter, M (2013): Canine intracranial neoplasms: Radiation therapy and survival analysis of 35 cases. ESVONC Congress, Lisbon, PORTUGAL, Portugal, MAY 30 - JUN 1, 2013. Veterinary and Comparative Oncology

Publizierter (zitierfähiger) Beitrag für wissenschaftliche Veranstaltung in Proceedings (A2)

Flickinger, I; Pakozdy, A; Leschnik, M; Kneissl, S; Tichy, A; Wolfesberger, B; Kleiter, M (2013): Canine intracranial neoplasms: Radiation therapy and survival analysis of 35 cases. 6-6.-ESVONC Congress; MAY 30 - JUN 1, 2013; Lissabon, PORTUGAL.

Flickinger, I; Wolfesberger, B; Pagitz, M; Willmann, M; Kleiter, M (2013): Adjuvant immunotherapy for canine malignant melanoma patients with ONCEPT TM: a single-center experience. -23.ECVIM-Congress; SEP 12-14, 2013; Liverpool, UNITED KINGDOM.

Wolfesberger, B (2013): Medikamentöse Therapie und Prognose von Mammakarzinomen bei Hunden und Katzen. 1148-1149.-28. VÖK Jahrestagung; SEP 20-22, 2013; Salzburg, AUSTRIA.

2012

Zeitschriftenaufsatz

** Wolfesberger, B; Tichy, A; Affenzeller, N; Galler, A; Shibly, S; Schwendenwein, I (2012): Clinical outcome of 73 cases with feline panleukopenia. Wien Tierarztl Monat (99), 9-10 235-241.

** Wolfesberger, B; Tonar, Z; Fuchs-Baumgartinger, A; Walter, I; Skalicky, M; Witter, K; Thalhammer, JG; Pagitz, M; Kleiter, M (2012): Angiogenic markers in canine lymphoma tissues do not predict survival times in chemotherapy treated dogs. Res Vet Sci. 2012; 92(3):444-450

Publizierter (zitierfähiger) Beitrag für wissenschaftliche Veranstaltung in Proceedings (A2)

Flickinger, I; Pakozdy, A; Leschnik, M; Wolfesberger, B; Kleiter, M (2012): Radiation therapy in dogs with intracranial neoplasms. -World Veterinary Cancer Conference; MAR 1-3, 2012; Paris, FRANCE.

Kleiter, M; Fiola, I; Flickinger, I; Kosik, S; Tichy, A; Wolfesberger, B (2012): First patient cohort of feline fibrosarcoma treated with curative intent radiotherapy at the University of Veterinary Medicine. 90-90.-ACVR/VCO; OCT 17-20, 2012; Las Vegas, USA.

Rütgen, BC; Flickinger, I; Wolfesberger, B; Litschauer, B; Fuchs-Baumgartinger, A; Essler, SE; Saalmüller, A; Schwendenwein, I (2012): Case Report: Cutaneous T-cell lymphoma - Sézary Syndrome in a Boxer. 141--14th Conference of the European Society of Veterinary Clinical Pathology ECVCP 2012; JUL 4-7, 2012; Ljubljana, Slovenia.

Rütgen, BC; Käser, T; Mair, K; Gerner, W; Wolfesberger, B; Saalmüller, A; Schwendenwein, I (2012): Susceptibility of the canine lymphoma B cell line CLBL-1 to the cell cycle phase non specific cytotoxic drug doxorubicin. -ACVP/ACVCP annual meeting 2012; DEZ 1-5, 2012; Seattle, USA.

Sabitzer, S; Schneider, M; Grdseloff, N; Wolfesberger, B; Walter, I; Klein, D (2012): Comparative gene expression profiling of feline lymphomas. -11th International Feline Retrovirus Research Symposium; AUG 26-29, 2012; Leipzig, GERMANY.

2011

Zeitschriftenaufsatz

** Jais, A; Klein, D; Wolfesberger, B; Walter, I (2011): Gene expression profile of vascular endothelial growth factor (VEGF) and its receptors in various cell types of the canine lymph node using laser capture microdissection (LCM). Vet Immunol Immunopathol. 2011; 140(3-4):207-214

** Wolfesberger, B; Fuchs-Baumgartinger, A; Schwendenwein, I; Zeugswetter, F; Shibly, S (2011): Sudden death in a dog with lymphoplasmacytic hypophysitis. J Comp Pathol. 2011; 145(2-3):231-234

Publizierter (zitierfähiger) Beitrag für wissenschaftliche Veranstaltung in Proceedings (A2)

Shibly, S; Galler, A; Wolfesberger, B; Hirt, RA; Schwendenwein, I (2011): Treatment of canine idiopathic immune-mediated haemolytic anaemia without anticoagulants. Is less more?. -21st ECVIM-CA Congress; SEP 8-10, 2011; Seville, SPAIN.

Wolfesberger, B (2011): Staging - was steckt dahinter. 299-301.-26. VÖK-Tagung; SEP 16-18, 2011; Salzburg, AUSTRIA.

Wolfesberger, B (2011): Osteosarcome der Gliedmaßen. 353-356.-26. VÖK-Tagung; SEP 16-18, 2011; Salzburg, AUSTRIA.

2010

Zeitschriftenaufsatz

** Kleiter, M; Tichy, A; Willmann, M; Pagitz, M; Wolfesberger, B (2010): Concomitant liposomal doxorubicin and daily palliative radiotherapy in advanced feline soft tissue sarcomas. Vet Radiol Ultrasound. 2010; 51(3):349-355

** Wolfesberger, B (2010): A quick guide through the feline lymphoma complex. Wien Tierarztl Monatsschr (97), 5-6 114-124.

** Wolfesberger, B; Tonar, Z; Gerner, W; Skalicky, M; Heiduschka, G; Egerbacher, M; Thalhammer, JG; Walter, I (2010): The tyrosine kinase inhibitor sorafenib decreases cell number and induces apoptosis in a canine osteosarcoma cell line. Res Vet Sci. 2010; 88(1):94-100

** Zeugswetter, F; Kleiter, M; Wolfesberger, B; Schwendenwein, I; Miller, I (2010): Elevated fructosamine concentrations caused by IgA paraproteinemia in two dogs. J Vet Sci. 2010; 11(4):359-361
Open Access Logo

Publizierter (zitierfähiger) Beitrag für wissenschaftliche Veranstaltung in Proceedings (A2)

Kleiter, M; Schöps, CA; Tichy, A; Kosik, S; Willmann, M; Pagitz, M; Wolfesberger, B (2010): Installation of a linear accelerator at the University of Veterinary Medicine Vienna. -ACVR-Scientific Meeting; AUG 16-19, 2010; Ashville, NC, USA.

Rütgen, B; Sabitzer, S; Wolfesberger, B; Kleiter, M; Klein, D; Walter, I; Schwendenwein, I; Saalmüller, A; Hammer, SE (2010): Characterization of the canine B-cell line CLBL-1 in comparison with other canine cell lines using Gene Expression Profiling. -Annual VCS-Conference; OCT 29-NOV 1, 2010; San Diego, CA (USA).

Wolfesberger, B (2010): Mastzelltumoren. 321-325.-25. VÖK-Tagung; SEP 24-26, 2010; Salzburg, AUSTRIA.

Wolfesberger, B (2010): State of the art in canine lymphoma. 417-424.-25. VÖK-Tagung; SEP 24-26, 2010; Salzburg, AUSTRIA.

2009

Zeitschriftenaufsatz

** Willmann, M; Müllauer, L; Schwendenwein, I; Wolfesberger, B; Kleiter, M; Pagitz, M; Hadzijusufovic, E; Shibly, S; Reifinger, M; Thalhammer, JG; Valent, P (2009): Chemotherapy in canine acute megakaryoblastic leukemia: a case report and review of the literature. In Vivo. 2009; 23(6):911-918 Open Access Logo

Publizierter (zitierfähiger) Beitrag für wissenschaftliche Veranstaltung in Proceedings (A2)

Kleiter, M; Wolfesberger, B; Willmann, M; Pagitz, M; Tichy, A (2009): Liposomal doxorubicin and daily fractionated palliative radiotherapy in advanced feline fibrosarcomas. 232-232.-19th annual congress ECVIM; SEP 8-10, 2009; Porto, PORTUGAL.

Wolfesberger, B (2009): Das feline Lymphom. 185-190.-24. VÖK-Jahrestagung; SEP 18-20, 2009; Salzburg, AUSTRIA.

Wolfesberger, B (2009): Das canine Lymphom. 165-173.-24. VÖK-Jahrestagung; SEP 18-20, 2009; Salzburg, AUSTRIA.

Wolfesberger, B; Tonar, Z; Witter, K; Willmann, M; Kleiter, M; Pagitz, M; Skalicky, M; Thalhammer, JG; Walter, I (2009): Evaluation of Angiogenesis Markers and Clinical Outcome in Lymphoma Bearing Dogs. 234-234.-ECVIM Congress; SEP 8-10, 2009; Porto, PORTUGAL.

Wolfesberger, B; Willmann, M; Skalicky, M; Kleiter, M; Pagitz, M; Thalhammer, JG (2009): The Velcap-Protocol in Feline Lymphoma: an advisable treatment option?. 27-27.-ESVONC Congress; MAR 27-29, 2009; Visegrad, HUNGARY.

2008

Zeitschriftenaufsatz

** Tonar, Z; Egger, GF; Witter, K; Wolfesberger, B (2008): Quantification of microvessels in canine lymph nodes. Microsc Res Tech. 2008; 71(10):760-772

** Wolfesberger, B; Tonar, Z; Witter, K; Guija de Arespacohaga, A; Skalicky, M; Walter, I; Thalhammer, JG; Egger, GF (2008): Microvessel density in normal lymph nodes and lymphomas of dogs and their correlation with vascular endothelial growth factor expression. Res Vet Sci. 2008; 85(1):56-61

Pakozdy, A; Kneissl, S; Wolfesberger, B; Leschnik, M (2008): Seizure in boxer – a retrospektive study: 13 cases (1999-2005). Magazyn Weterynaryjny (1) 19-22.

Kongressbeitrag in einer Zeitschrift

** Rütgen, BC; de Arespacochaga, AG; Wolfesberger, B; Gerner, W; Hammer, SE; Willmann, M; Schwendenwein, I; Saalmüller, A (2008): Staging and diagnosis of non-Hodgkin's lymphoma in dogs - a comparative model for translational lymphoma research. Joint Annual Meeting of Immunology of the Austrian and German Societies (ÖGAI, DGfI), Vienna, Austria, Austria, September 3–6, 2008. Wien Klin Wochenschr (120), Suppl. 185-186.

Witter, K; Tonar, Z; Wolfesberger, B (2008): Assessment of microvessel density in lymph nodes of the dog - hot spot methods vs. systematic uniform random sampling. XXVII. Congreß of the European Association of Veterinary Anatomy, Budapest, HUNGARY, Hungary, July 23-26, 2008. Magyar Állatorvosok Lapja (Suppl. 3) 110.

Publizierter (zitierfähiger) Beitrag für wissenschaftliche Veranstaltung in Proceedings (A2)

Witter, K; Tonar, Z; Wolfesberger, B (2008): Assessment of microvessel density in lymph nodes of the dog ] hot spot methods vs. systematic uniform random sampling. -XXVIIth Congress of the EAVA; JUL 23-26, 2008; Budapest, HUNGARY.

2007

Zeitschriftenaufsatz

** Wolfesberger, B; Guija de Arespacohaga, A; Willmann, M; Gerner, W; Miller, I; Schwendenwein, I; Kleiter, M; Egerbacher, M; Thalhammer, JG; Muellauer, L; Skalicky, M; Walter, I (2007): Expression of vascular endothelial growth factor and its receptors in canine lymphoma. J Comp Pathol. 2007; 137(1):30-40

Kongressbeitrag in einer Zeitschrift

Tonar, Z; Egger, GF; Witter, K; Wolfesberger, B (2007): Quantification of microvessels in healthy and tumorous canine lymph nodes. 9. Congress of the European Association of Clinical Anatomy (EACA), Prag, CZECH , Sep 5-8, 2007. Surgical and Radiologic Anatomy (29) 461-462.

Publizierter (zitierfähiger) Beitrag für wissenschaftliche Veranstaltung in Proceedings (A2)

Willmann, M; Schwendenwein, I; Wolfesberger, B; Kleiter, M. Guija de Arespacochaga, A; Valent, P (2007): Unexpected long term survival in a canine AML patient treated with a high dose chemotherapy protocol without bone marrow transplantation: a case report. 34-34.-ESVONC Spring Meeting; 01.-02.04.2007; Ljubljana.

Wolfesberger, B; Egerbacher, M; Thalhammer, JG; Walter, I (2007): Sorafenib inhibits Proliferation in Canine Osteosarcoma Cells: An In Vitro Study. 201-201.-17. ECVIM-CA Kongreß; 13.-15.09.2007; Budapest.

Wolfesberger, B; Tonar, Z; Witter, K; Guija de Arespacohaga, A; Skalicky, M; Walter, I; Thalhammer, J.G; Egger, G (2007): Evaluation of angiogenesis in normal lymph nodes and lymphomas of dogs. 31-31.-ESVONC Annual Congress; 24.-25.03.2007; Cambridge.

2006

Zeitschriftenaufsatz

** Pakozdy, A; Kneissl, S; Wolfesberger, B; Leschnik, M (2006): Krampfanfälle beim Boxer: eine retrospektive Studie (1999-2005). Veterinary Medicine Austria / Wiener Tierärztliche Monatsschrift (93) 270-276.

** Wolfesberger, B; Hoelzl, C; Walter, I; Reider, GA; Fertl, G; Thalhammer, JG; Skalicky, M; Egerbacher, M (2006): In vitro effects of meloxicam with or without doxorubicin on canine osteosarcoma cells. J Vet Pharmacol Ther. 2006; 29(1):15-23

** Wolfesberger, B; Walter, I; Hoelzl, C; Thalhammer, JG; Egerbacher, M (2006): Antineoplastic effect of the cyclooxygenase inhibitor meloxicam on canine osteosarcoma cells. Res Vet Sci. 2006; 80(3):308-316

Publizierter (zitierfähiger) Beitrag für wissenschaftliche Veranstaltung in Proceedings (A2)

Guija de Arespacochaga, A; Gerner, W; Shibly, S; Wolfesberger, B; Leschnik, M; Schwendenwein, I (2006): Two cases of lymphoblastic lymphoma in dogs expressing CD3 and CD79a. Annual Meeting ESVCP/ECVCP, Cambridge, 06.09.-08.09.2006. Annual Meeting ESVCP/ECVCP, Cambridge, 06.09.-08.09.2006.

Guija de Arespacochaga, A; Gerner, W; Wolfesberger, B; Saalmüller, A; Willmann, M; Schwendenwein, I (2006): Co-Expression of CD3 and CD79a in canine lymphomas. 120-120.-Annual Meeting ESVCP/ECVCP; 06.09.-08.09.2006; Cambridge.

Willmann, M; Guija, A; Wolfesberger, B; Müllauer, L (2006): The value of anti – PAX5 immunostaining in paraffin-embedded sections of canine lymphomas. A novel (pan pre-B) and B-cell marker. 108--26th Annual VCS Conference ; Oct 19-22, 2006; Georgia, USA.

Willmann, M; Schwendenwein, I; Wolfesberger, B; Kleiter, M; Guija, A; Valent, P (2006): Unexpected long term survival in a canine AML patient treated with a high dose chemotherapy protocol without bone marrow transplantation. A case report. -26th Annual VCS Conference; OCT 19-22, 2006; Georgia, USA.

Willmann, M; Schwendenwein, I; Wolfesberger, B; Kleiter, M; Guija, A; Valent, P (2006): Unexpected long term survival in a canine AML patient treated with a high dose chemotherapy protocol without bone marrow transplantation. A case report. 34--ESVONC Spring Meeting ; April 1-2, 2006; Slovenia.

Wolfesberger, B; Guija de Arespacochaga, A; Willmann, M; Schwendenwein, I; Gerner, W; Miller, I; Egerbacher, M; Kleiter, M; Thalhammer, JG; Walter, I (2006): Vascular endothelial growth factor and its receptors in lymphomas of dogs. 172-172.-16. ECVIM-CA Congress; 14.-16.09.2006; Amsterdam.

2004

Wolfesberger, B; Walter, I; Hoelzl, C; Thalhammer, JG; Boeck, P; Egerbacher, M (2004): The selective Cyclooxygenase-2 inhibitor Meloxicam shows an antineoplastic effect on canine osteosarcoma cells. -AACR/JCA Conference (American Association for Cancer Research) - Advances in Cancer Research; JAN 24-30, 2004; Hawaii, USA.

2001

Zeitschriftenaufsatz

** Egerbacher, M; Wolfesberger, B; Gabler, C (2001): In vitro evidence for effects of magnesium supplementation on quinolone-treated horse and dog chondrocytes. Vet Pathol. 2001; 38(2):143-148
Open Access Logo

2000

** Egerbacher, M; Seiberl, G; Wolfesberger, B; Walter, I (2000): Ciprofloxacin causes cytoskeletal changes and detachment of human and rat chondrocytes in vitro. Arch Toxicol. 2000; 73(10-11):557-563

1999

** Egerbacher, M; Wolfesberger, B; Walter, I; Seirberl, G (1999): Integrins mediate the effects of quinolones and magnesium deficiency on cultured rat chondrocytes. Eur J Cell Biol. 1999; 78(6):391-397

Kongressbeitrag in einer Zeitschrift

Seiberl G; Egerbacher M; Walter I; Wolfesberger B (1999): A new method for testing the chondrotoxicity of ciprofloxacin. Satellite Symposium European Society of Clinical Microbiology and Infectious Diseases, Berlin, Germany, Germany, MAR 21–24, 1999. Clinical Microbiology Infection (5), S3 148-148.

Dissertation

Wolfesberger, B (1999): Wirkung von Quinolon auf Rattenchondrozyten in vitro. Dissertation, Vet. Med. Univ. Wien, pp. 63.

1998

Zeitschriftenaufsatz

** Walter, I; Egerbacher, M; Wolfesberger, B; Seiberl, G (1998): Confocal laser scanning microscopy of chondrocytes in vitro: cytoskeletal changes after quinolone treatment. Scanning (20), 7 511-515.

Kongressbeitrag in einer Zeitschrift

** Walter, I; Wolfesberger, B; Egerbacher, M; Seiberl, G (1998): Confocal Laser Scanning Microscopy of Chondrocytes in Vitro: Cytoskeletal Protein Changes after Quinolone Treatment. Scanning 98, Baltimore, Maryland, MAY 10-12, 1998. Scanning (20), 3 222-223.

© Veterinärmedizinische Universität Wien Hilfe und DownloadsErklärung zur Barrierefreiheit